merit
rapid
safe
sensit
specif
tool
accur
diagnosi
sarscov
infect
outbreak
sever
acut
respiratori
syndrom
sar
caus
newli
identifi
coronaviru
sarscov
detect
earli
sarscov
infect
onestep
realtim
quantit
revers
transcriptionpolymeras
chain
reaction
rtpcr
assay
develop
could
simultan
detect
nucleocapsid
n
membran
spike
gene
sarscov
pcr
condit
use
either
appli
biosystem
abi
prism
sequenc
detect
system
roch
lightcycl
sensit
assay
evalu
use
cell
culturederiv
virus
vitro
transcrib
viral
rna
clinic
specimen
sarss
n
primerprob
set
describ
paper
could
detect
one
ten
copi
vitro
transcrib
n
rna
per
test
use
abi
roch
assay
system
rel
sensit
detect
cell
culturederiv
sarscov
pfutest
respect
show
sarsn
compar
detect
effici
primer
set
design
center
diseas
control
prevent
addit
sarss
sarsm
also
demonstr
equival
sensit
commerci
avail
realart
hpacoronaviru
reagent
artu
rel
sensit
primerprob
set
also
examin
use
human
sera
spike
virus
clinic
specimen
four
confirm
sar
patient
similar
result
obtain
specif
test
sequenc
align
show
primerprob
set
anneal
perfectli
isol
sarscov
cross
detect
coronavirus
human
respiratori
tractassoci
virus
therefor
compat
abi
roch
system
multiplegen
detect
assay
also
march
novel
coronaviru
identifi
associ
sever
acut
respiratori
syndrom
sar
ksiazek
et
al
peiri
et
al
new
emerg
viru
caus
pathogen
sar
name
sarsassoci
coronaviru
sarscov
kuiken
et
al
peiri
et
al
genom
coronavirus
nucleotid
nt
largest
found
rna
virus
featur
gene
order
polymeas
rep
spike
envelop
e
membran
nucleocapsid
n
short
untransl
region
termini
rep
gene
product
translat
genom
rna
remain
viral
structur
protein
e
n
translat
subgenom
mrna
featur
coterminu
leader
sequenc
therefor
transcript
abund
rna
speci
coronavirus
holm
genom
organ
sarscov
similar
coronavirus
phylogenet
analysi
indic
distinct
new
group
within
genu
coronaviru
holm
brown
tetro
ruan
et
al
tsui
et
al
yeh
et
al
addit
sarscov
three
group
coronavirus
group
virus
infect
mammal
group
virus
restrict
avian
holm
virus
belong
famili
coronavirida
mani
virus
famili
may
elicit
respiratori
enter
diseas
human
anim
lai
holm
ksiazek
et
al
group
human
coronavirus
respect
respons
upper
respiratori
tract
ill
lai
holm
besid
coronavirus
mani
virus
adenovirus
influenza
virus
also
induc
lesion
respiratori
tract
given
initi
symptom
sarscov
infect
similar
respiratori
tract
ill
caus
virus
essenti
develop
diagnost
method
distinguish
infect
furthermor
mani
individu
healthcar
worker
suffer
sar
expos
sarsaffect
patient
fever
initi
stage
poutanen
et
al
avail
rapid
sensit
specif
accur
diagnost
test
confirm
sarscov
infect
essenti
immedi
alert
healthcar
profession
turn
prevent
other
come
contact
probabl
sar
individu
accord
world
health
organ
current
diagnost
methodolog
sarscov
infect
includ
molecular
test
use
revers
transcriptasepolymeras
chain
reaction
rtpcr
antibodi
test
enzym
link
immunosorb
assay
elisa
immunofluores
assay
ifa
viru
isol
use
vero
cell
method
use
rtpcr
detect
sarscov
viral
rna
safer
faster
cell
culturebas
assay
addit
realtim
rtpcr
assay
system
employ
fluoresc
dna
probe
exonucleas
assay
taqman
develop
varieti
pathogen
includ
sarscov
lanciotti
et
al
nijhui
et
al
warrilow
et
al
poon
et
al
emeri
et
al
taqman
detect
assay
offer
advantag
tradit
rtpcr
techniqu
increas
sensit
specif
decreas
contamin
high
throughput
capabl
provid
absolut
quantit
bustin
howev
laboratori
perform
sarscov
specif
rtpcr
test
still
adopt
qualitycontrol
procedur
includ
reconfirm
posit
specimen
also
suggest
amplifi
second
genom
region
sarscov
may
increas
test
specif
purpos
realtim
quantit
rtpcr
qpcr
assay
develop
run
univers
rtpcr
condit
amplifi
n
gene
sarscov
simultan
quick
sensit
specif
detect
viru
moreov
primer
probe
set
pcr
condit
illustr
could
appli
abi
prism
roch
lightcycl
system
whichev
avail
laboratori
sarscov
use
studi
isol
sputum
sampl
sar
case
hope
hospit
taipei
epidem
stageii
outbreak
yeh
et
al
viru
prepar
vero
cell
inocul
sarscov
virus
prepar
day
cytopathogen
effect
observ
harvest
virus
quantifi
plaqu
assay
serial
dilut
later
use
beati
et
al
influenza
viru
influenza
b
viru
respiratori
syncyti
viru
adenoviru
purchas
american
type
cultur
collect
manassa
va
transmiss
gastroenter
viru
tgev
provid
dr
konan
peck
academia
sinica
taiwan
sarscov
manipul
laboratori
certifi
biosafeti
clinic
sampl
use
studi
collect
sar
patient
late
convalesc
stage
sarscov
infect
four
sar
patient
seen
triserv
gener
hospit
stage
ii
epidem
taiwan
confirm
meet
world
health
organ
definit
probabl
sar
case
mean
show
typic
clinic
symptom
confirm
sarscov
infect
rtpcr
sarsspecif
primer
emeri
et
al
confirm
made
center
diseas
control
taiwan
n
subfrag
sequenc
nt
nt
nt
respect
sarscov
pcr
amplifi
clone
pgst
pdrive
obtain
pgstm
pcdnan
respect
bam
hi
fragment
pgstm
subclon
bam
hi
site
produc
pgemm
vitro
transcript
pcdnan
pgemm
linearl
hind
iii
xba
nco
respect
transcrib
use
pcdnan
pgemm
rna
polymeras
transcript
kit
promega
madison
wi
vitro
transcrib
rna
purifi
use
rneasi
mini
kit
qiagen
subject
tenfold
serial
dilut
concentr
copiesml
depctreat
water
use
standard
qpcr
viral
rna
purifi
ml
inocul
vero
lysat
use
qiaamp
viral
rna
kit
qiagen
valencia
ca
elut
ml
elut
buffer
hong
kong
viru
strain
obtain
center
diseas
control
taiwan
viral
rna
prepar
institut
prevent
medicin
nation
defens
medic
center
taiwan
primer
taqman
probe
sarss
sarsm
sarsn
spike
membran
nucleocapsid
respect
sarscov
select
use
primer
express
tm
softwar
tabl
appli
biosystem
foster
citi
ca
primerprob
set
subject
blast
search
ensur
align
sequenc
sarscov
primerprob
sequenc
ident
variou
isol
sarscov
includ
urbani
cuhk
taqman
probe
label
fam
report
dye
label
quencher
dye
tamra
primer
synthes
mwg
biotech
ag
ebersberri
germani
purifi
highpressur
liquid
chromatographi
realtim
quantit
rtpcr
assay
perform
use
either
abi
prism
sequenc
detect
system
appli
biosystem
roch
lightcycl
roch
diagnost
appli
scienc
mannheim
germani
taqman
onestep
rtpcr
master
mix
appli
biosystem
superscript
iii
platinum
onestep
quantit
rtpcr
system
invitrogen
corpor
groningen
netherland
appli
abi
prism
qpcr
roch
lightcycl
superscript
iii
platinum
use
taqman
onestep
rtpcr
mixtur
abi
prism
contain
nm
pcr
primer
nm
probe
ml
rna
use
final
volum
ml
condit
rtpcr
min
min
follow
cycl
sec
min
superscript
iii
platinum
onestep
quantit
rtpcr
abi
prism
system
reaction
began
min
min
follow
cycl
sec
sec
roch
lightcycl
system
superscript
iii
onestep
rtpcr
use
compris
ml
reaction
mix
ml
mm
mgso
ml
superscript
iii
rtplatinum
taqmix
primersprob
final
concentr
nm
ml
rna
ml
reaction
mixtur
condit
rtpcr
min
min
follow
cycl
sec
sec
rtpcr
cycl
number
fluoresc
level
increas
interassaycalibr
threshold
valu
defin
threshold
cycl
number
c
abi
prism
roch
lightcycl
cross
point
cp
c
valu
non
templat
control
ntc
abi
system
cp
valu
ntc
lightcycl
system
evalu
sensit
sarss
n
qpcr
assay
human
sera
specimen
sarscov
spike
human
blood
sampl
three
healthi
donor
describ
previous
huang
et
al
sampl
use
mimic
blood
specimen
correspond
viremia
stage
virionsml
blood
viremia
sera
incub
room
temperatur
hr
follow
centrifug
rpm
min
viral
rna
isol
specimen
analyz
artu
kit
sarss
n
taqman
rtpcr
techniqu
set
qpcr
primer
design
detect
sarscov
spike
membran
nucleocapsid
n
region
design
sarss
n
respect
region
tabl
examin
sensit
primer
viral
rna
prepar
sarscov
infect
vero
cell
use
templat
amount
virus
obtain
serial
dilut
vero
cell
pfuml
use
rna
isol
use
abi
prism
platform
n
viral
rna
detect
pfu
ml
virus
respect
tabl
ii
correspond
sensit
pfu
per
ml
reaction
describ
materi
method
commerci
avail
qpcr
kit
artu
cdc
design
primerprob
set
test
parallel
primer
order
compar
sensit
primerprob
set
detect
sarscov
polymeras
region
artu
reveal
similar
sensit
sarss
tabl
ii
sarsn
primer
exhibit
nearli
tenfold
sensit
former
tabl
ii
data
suggest
primer
probe
set
use
detect
sarscov
n
region
sensit
design
polymeras
region
determin
absolut
sensit
primer
probe
set
vitro
transcrib
n
subfrag
transcript
use
standard
fig
vitro
transcrib
rna
dilut
serial
yield
copi
per
microlit
rna
use
templat
qpcr
tabl
iii
show
low
copi
subfrag
rna
copi
n
rna
could
detect
effici
use
abi
prism
machin
similar
sensit
also
obtain
use
roch
lightcycl
system
tabl
iii
soon
rna
amount
went
level
specifi
could
detect
either
qpcr
platform
could
produc
variabl
posit
rate
tabl
iii
examin
specif
sarss
n
primer
probe
set
rna
coronavirus
virus
could
induc
clinic
symptom
upper
respiratori
tract
infect
test
tabl
iv
show
primer
set
could
detect
sarscov
isol
taiwan
hong
kong
use
abi
prism
system
neither
group
coronavirus
transmiss
gastroenter
viru
virus
adenoviru
influenza
respiratori
syncyti
virus
could
detect
use
primerprob
set
tabl
iv
result
demonstr
sarss
n
primerprob
set
highli
specif
sarscov
could
use
diagnost
tool
detect
sar
viru
test
sensit
applic
sarss
n
primerprob
set
human
sera
specimen
sarscov
obtain
inocul
vero
cell
spike
normal
human
sera
three
individu
follow
rna
purif
qpcr
assay
qpcr
assay
use
sarss
n
primerprob
set
could
easili
detect
sarscov
genom
spike
sera
contain
pfuml
virus
equival
one
virion
per
test
tabl
v
expect
sarsn
exhibit
best
sensit
among
test
use
sarss
artu
primerprob
set
tabl
v
sarsm
n
qpcr
assay
appli
clinic
specimen
four
confirm
sar
patient
sarsn
could
detect
presenc
sarscov
specimen
urin
serum
throat
swab
effici
primerprob
set
tabl
vi
primerprob
set
design
cdc
atlanta
georgia
emeri
et
al
display
best
sensit
sampl
among
variou
qpcr
assay
includ
usag
artu
bniout
assay
tabl
vi
sensit
sarsm
primerprob
specimen
equival
artu
bniout
less
sensit
sarsn
primerprob
set
tabl
vi
assay
produc
neg
result
nonsar
specimen
specif
sarscov
data
shown
data
support
test
use
cell
culturederiv
virus
vitro
transcrib
rna
templat
suggest
sarsm
n
qpcr
assay
suitabl
clinic
applic
studi
three
primerprob
set
univers
pcr
program
design
could
detect
three
gene
sarscov
simultan
realtim
quantit
rtpcr
inhous
qpcr
assay
use
two
reagent
system
altern
appli
abi
roch
platform
describ
materi
method
abi
roch
instrument
avail
take
less
hr
pcr
setup
obtain
six
sarscov
diagnost
quantit
result
combin
two
assay
platform
three
primerprob
set
therefor
multigen
quantit
rtpcr
assay
provid
data
sar
diagnosi
offer
advantag
doublecheck
presenc
sarscov
rna
specimen
well
test
specif
accord
guidelin
suggest
posit
rtpcr
result
obtain
sar
specimen
need
reconfirm
second
round
rtpcr
test
either
repeat
pcr
test
perform
differ
rtpcr
assay
multigen
realtim
rtpcr
assay
posit
detect
ratio
three
independ
experi
definit
posit
interpret
tabl
ii
ideal
candid
clinic
applic
owe
capabl
run
three
qpcr
assay
simultan
plu
ad
benefit
satisfi
posit
criteria
determin
sarscov
infect
recommend
requir
singl
round
pcr
test
detect
multipl
viral
gene
import
prevent
spread
sarscov
outbreak
save
time
reconfirm
also
enabl
rapid
classif
manag
probabl
sar
case
addit
abil
produc
time
result
singlestep
closedtub
natur
realtim
rtpcr
minim
potenti
laboratori
crosscontamin
compar
nest
rtpcr
suggest
sensit
primerprob
set
equival
commerci
artu
kit
cdc
primer
set
examin
use
cell
culturederiv
virus
tabl
ii
assay
highli
sensit
valid
detect
rate
copi
viral
rna
depend
target
gene
amplifi
tabl
iii
rna
contain
cotermin
nucleocapsid
region
abund
speci
holm
ideal
amplif
target
exhibit
highest
detect
sensit
inde
sarsn
primer
set
could
detect
copi
viral
rna
sensit
primer
set
regardless
whether
templat
obtain
cell
culturederiv
virus
vitro
transcrib
viral
rna
clinic
specimen
tabl
iivi
primerprob
set
detect
sarscov
n
region
cdc
also
display
higher
sensit
detect
viral
genom
n
region
tabl
ii
vi
data
suggest
primer
set
detect
sarscov
n
region
best
choic
high
sensit
detect
differ
cell
culturederiv
virus
vitro
transcrib
viral
rna
detect
sensit
pfu
vs
copi
rna
may
attribut
presenc
defect
virion
cultur
supernat
sinc
genet
materi
defect
virion
detect
molecularli
unabl
form
plaqu
use
cell
culturebas
assay
quantif
viru
titer
vabret
et
al
vitro
transcrib
sarscov
rna
suitabl
serv
absolut
quantit
standard
furthermor
use
recombin
rna
elimin
need
danger
viru
prepar
ideal
common
laboratori
spike
experi
japanes
enceph
viru
jev
enteroviru
show
taqman
qpcr
assay
work
well
varieti
spike
materi
without
appar
inhibit
nijhui
et
al
huang
et
al
sensit
sarss
n
artu
qpcr
assay
use
sarscov
spike
human
sera
lower
use
cell
culturederiv
virus
differ
approxim
three
cycl
qpcr
assay
use
two
type
templat
tabl
ii
v
possibl
much
nake
sarscov
rna
cell
culturederiv
viral
prepar
sensit
certain
degrad
agent
human
sera
rnase
onehour
incub
spike
virus
room
temperatur
see
materi
method
howev
sensit
sarss
n
qpcr
assay
sarscov
spike
human
sera
satisfi
level
low
sizun
et
al
avellon
et
al
coira
et
al
escor
et
al
b
cp
valu
fluoresc
signal
detect
tabl
v
suggest
assay
may
use
clinic
specimen
without
appar
inhibit
due
sar
specimen
control
polici
taiwan
unabl
acquir
clinic
sampl
sar
patient
acut
phase
avail
clinic
specimen
mostli
obtain
last
stage
sarscov
infect
therefor
viral
load
may
reduc
sampl
result
rais
host
immun
respons
late
phase
may
also
reason
c
valu
specimen
rel
higher
acut
phase
howev
specimen
sarsn
qpcr
assay
result
good
cdc
primerprob
evalu
mani
human
clinic
sampl
emeri
et
al
sensit
sarsm
qpcr
lower
sarsn
better
artu
kit
bniout
clinic
sampl
tabl
vi
base
comparison
assay
may
suitabl
clinic
diagnosi
acut
phase
sar
present
cdc
artu
kit
blast
analysi
primerprob
sequenc
specif
test
use
sever
virus
demonstr
sarss
n
primerprob
set
highli
specif
sarscov
tabl
iv
crossreact
coronavirus
upper
respiratori
tractassoci
virus
augment
applic
qpcr
primerprob
set
differenti
infect
sarscov
virus
caus
ill
similar
clinic
symptom
initi
stage
sar
addit
sarss
n
primerprob
set
shown
distinguish
clinic
specimen
four
confirm
sar
patient
nonsar
individu
tabl
vi
dada
shown
result
indic
qpcr
assay
highli
specif
sarscov
besid
purpos
diagnos
sarscov
infect
quantifi
rtpcr
assay
also
use
replac
tradit
viru
quantit
method
plaqu
assay
tradit
assay
laborintens
timeconsum
danger
comparison
assay
ideal
substitut
use
laboratori
research
vaccin
antisar
drug
develop
summar
sarss
n
primerprob
set
onestep
easi
setup
assay
compat
dual
mainstream
qpcr
system
mean
flexibl
tool
select
oper
addit
assay
provid
accur
diagnosi
sarscovrel
clinic
sampl
cheaper
homemad
reagent
inde
ideal
conveni
assay
everi
laboratori
work
sarscov
diagnosi
vaccin
antivir
drug
develop
